![]() |
|
|
Vol. 16, Issue 10, 4982-4991, October 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Cell Biology, School of Medicine, University of Virginia Health System, Charlottesville, VA 22908
Submitted March 28, 2005;
Revised July 21, 2005;
Accepted July 25, 2005
Monitoring Editor: Jean Schwarzbauer
A disintegrin and a metalloprotease (ADAM) family members have been implicated in many biological processes. Although it is recognized that recombinant ADAM disintegrin domains can interact with integrins, little is known about ADAM-integrin interactions in cellular context. Here, we tested whether ADAMs can selectively regulate integrin-mediated cell migration. ADAMs were expressed in Chinese hamster ovary cells that express defined integrins (
4
1,
5
1, or both), and cell migration on full-length fibronectin or on its
4
1 or
5
1 binding fragments was studied. We found that ADAMs inhibit integrin-mediated cell migration in patterns dictated by the integrin binding profiles of their isolated disintegrin domains. ADAM12 inhibited cell migration mediated by the
4
1 but not the
5
1 integrin. ADAM17 had the reciprocal effect; it inhibited
5
1- but not
4
1-mediated cell migration. ADAM19 and ADAM33 inhibited migration mediated by both
4
1 and
5
1 integrins. A point mutation in the ADAM12 disintegrin loop partially reduced the inhibitory effect of ADAM12 on cell migration on the
4
1 binding fragment of fibronectin, whereas mutations that block metalloprotease activity had no effect. Our results indicate that distinct ADAMs can modulate cell migration mediated by specific integrins in a pattern dictated, at least in part, by their disintegrin domains.
Abbreviations used: ADAM, a disintegrin and metalloprotease; CCBD, central cell binding domain; CHO, Chinese hamster ovary; CNC, cranial neural crest; FBS, fetal bovine serum; GFP, green fluorescence protein; FN, fibronectin; PBS, phosphate buffered saline.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
Address correspondence to: Judith M. White (jw7g{at}virginia.edu).
This article has been cited by other articles:
![]() |
N. V. Verbisck, E. T. Costa, F. F. Costa, F. P. Cavalher, M. D.M. Costa, A. Muras, V. A. Paixao, R. Moura, M. F. Granato, D. F Ierardi, et al. ADAM23 Negatively Modulates {alpha}v{beta}3 Integrin Activation during Metastasis Cancer Res., July 1, 2009; 69(13): 5546 - 5552. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Schornberg, C. J. Shoemaker, D. Dube, M. Y. Abshire, S. E. Delos, A. H. Bouton, and J. M. White {alpha}5{beta}1-Integrin controls ebolavirus entry by regulating endosomal cathepsins PNAS, May 12, 2009; 106(19): 8003 - 8008. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zigrino, J. Steiger, J. W. Fox, S. Loffek, A. Schild, R. Nischt, and C. Mauch Role of ADAM-9 Disintegrin-Cysteine-rich Domains in Human Keratinocyte Migration J. Biol. Chem., October 19, 2007; 282(42): 30785 - 30793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Franovic, I. Robert, K. Smith, G. Kurban, A. Pause, L. Gunaratnam, and S. Lee Multiple Acquired Renal Carcinoma Tumor Capabilities Abolished upon Silencing of ADAM17 Cancer Res., August 15, 2006; 66(16): 8083 - 8090. [Abstract] [Full Text] [PDF] |
||||